© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
New Leaf Ventures Inc (NLVVF) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 4.25K |
| Aug 14, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 8.84K |
| Aug 03, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25K |
| Apr 13, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 100 |
| Mar 30, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 350 |
| Jan 15, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.2K |
| Jan 08, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 200 |
| Dec 11, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 648 |
| Sep 18, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 15, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 300 |
| Sep 11, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 08, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 04, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Sep 02, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 300 |
| Aug 26, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 22, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 300 |
| Aug 15, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 12, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 11, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 0 |
| Aug 08, 2025 | 0.00 | 0.00 | 0.00 | 0.00 | 3K |
New Leaf Ventures Inc. specializes in the full lifecycle of cannabis and related goods, encompassing their processing, packaging, marketing, and distribution. The company's diverse brand portfolio includes popular names such as dama, Green State, Tasty Tokes, Astara, Goodies, and Dama Hemp. Beyond its core product operations, New Leaf Ventures also extends its expertise through consulting services, the leasing of real estate and equipment, intellectual property licensing, and comprehensive management solutions. Founded in 2018, the company's headquarters are situated in Vancouver, Canada.
| Employees | 12 |
| Beta | 3.6 |
| Sales or Revenue | $1.98M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |